Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2009
11/11/2009CN100558368C Method and material for treating immune diseases
11/11/2009CN100558367C Method for enhancing the effectiveness of cancer therapies
11/11/2009CN100558366C Use of oligose ester in preventing and treating depression
11/11/2009CN100558365C Conjugated anti-psychotic drugs and uses thereof
11/11/2009CN100558364C Combination of brimonidine and timolol for topical ophthalmic use
11/11/2009CN100558363C Medicinal composition for treating moist wart
11/11/2009CN100558362C Use of a trioxopyrimidine for the treatment and prevention of bronchial inflammatory diseases
11/11/2009CN100558361C Methods of improving skin quality
11/11/2009CN100558360C Amelioration of macular degeneration and other ophthalmic diseases
11/11/2009CN100558359C Remedy for glomerular diseae
11/11/2009CN100558358C Method of treating and diagnosing sleep disordered breathing using zonisamide and means for carrying out the method
11/11/2009CN100558357C Medicine composition for treating mixed infectious disease
11/11/2009CN100558356C Method of using benzenesulphoamides that are cyclooxygenase-2-inhibitors in the treatment and prevention of neoplasia
11/11/2009CN100558355C Indol-5 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
11/11/2009CN100558354C Triptolide lactone ring derivatives as immunomodulators and anticancer agents
11/11/2009CN100558353C Application of chlorogenic acid in preparing medicine for treating small cell lung cancer
11/11/2009CN100558352C Omega-3 fatty acids for the treatment of canine ostheoarthritis
11/11/2009CN100558351C Compounds and methods for delivery of prostacyclin analogs
11/11/2009CN100558350C Improved transdermal delivery system
11/11/2009CN100558348C Sallowness preparation, its making method and quality control
11/11/2009CN100558345C Method for preparing vitamin A and vitamin E nano-sphere/microsphere double-embedding system
11/11/2009CN100558344C Solid formulation for dialysis and process for producing the same
11/11/2009CN100558258C Composition and foods for lowering glycemic index
11/10/2009US7615679 Method of producing polyunsaturated fatty acids, novel biosynthesis genes, and novel plant expression constructs
11/10/2009US7615664 E.g., 2 N-(2-Fluorophenyl)-5(S)-amino-4(S)-hydroxy-2(S)-isopropyl-7(S)-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methylnonanamide; renin inhibitors used for the treatment of hypertension, heart failure, glaucoma, myocardial infarction, kidney failure, restenoses or stroke
11/10/2009US7615657 Method of producing an oil extract from seeds of plants via a binary azeotropic solvent mixture
11/10/2009US7615643 Benzimidazole thiophene compounds
11/10/2009US7615642 Therapeutic compounds
11/10/2009US7615635 1-[2-Cyclopentylmethyl-3-(formyl-hydroxy-amino)-propionyl]-pyrrolidine-2-carboxylic acid (5-fluoro-1-oxy-pyridin-2-yl)-amide; inhibitors of peptidyl deformylase (PDF), antimicrobials and antibiotics
11/10/2009US7615632 Nine polymorphic crystal structures based on characteristics of powder X-ray diffraction pattern exhibiting peaks at diffraction angles and infrared spectrum; antitumor and -carcinogenic agents; brain and breast cancer; refractory anaplastic astrocytoma; malignant glioma; glioblastoma multiforme
11/10/2009US7615576 Prevention of neutrophil recruitment
11/10/2009US7615575 Compounds for the treatment of metabolic disorders
11/10/2009US7615574 Comprises chlorogenic acid and 3-o-p-Coumaryl quinic acid isolated from any plant parts of Piper betel
11/10/2009US7615573 Via amino ceramide-like compounds; lowering glycosphingolipid concentrations; Fabry's disease, Gaucher's disease
11/10/2009US7615572 Pyrrole and pyrazole DAAO inhibitors
11/10/2009US7615571 useful as synthetic intermediates to synthesize perindopril
11/10/2009US7615570 Antagonists to the vanilloid receptor subtype 1 (VR1) and uses thereof
11/10/2009US7615569 Inhibitors of ion channels
11/10/2009US7615568 3-[2-(cis-4-aminocyclohexyloxy)-4-methylsulfonylbenzoyl-amino]-N-(5-chloropyridin-2-yl)pyridine-2-carboxamide,; anticoagulant; platelet glycoprotein receptor antagonist; thrombosis; orally; acylation of amino-pyridine by (methylthio)benzoic acid followed by oxidation, alkylation, carbonylation
11/10/2009US7615567 Such as 2-exo-[5'-(3'-Amino-2'-fluoropyridinyl)]-7-azabicyclo[2.2.1]-heptane; Tourette's syndrome
11/10/2009US7615566 Substituted pyrrolidine and related compounds
11/10/2009US7615565 VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
11/10/2009US7615564 Such as N5-[1-(2-chlorobenzyl)tetrahydro-1H-3-pyrrolyl]-5-isoquinolylamine; Rho kinase inhibitors; hypertension, asthma, angina pectoris, cerebrovascular contraction, peripheral circulatory disorder, threatened premature birth, glaucoma, vision disorders, autoimmune diseases, chronic renal failure
11/10/2009US7615563 Compositions useful as inhibitors of voltage-gated sodium channels
11/10/2009US7615562 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents
11/10/2009US7615560 tricyclic cmpounds; e.g. 3-propyl-5,6,7,8-tetrahydro-3H-benzo[4,5]-thieno[2,3-d]pyrimidin-4-ylidene amine; personal hygiene product, an oral hygiene product, a skin product or a food
11/10/2009US7615558 6-arylmethylprazolo[3,4-d]pyrimidines
11/10/2009US7615557 Such as 1-(2-Chlorophenyl)-N-(7-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl)piperidine-4-carboxamide; vanilloid receptor antagonists; urological disorders; inflammation; urinary incontinence; benign prostatic hyperplasia
11/10/2009US7615556 Piperazinyl derivatives as modulators of chemokine receptor activity
11/10/2009US7615555 Piperidine derivatives as modulators of chemokine receptor CCR5
11/10/2009US7615554 Erastin and erastin binding proteins, and uses thereof
11/10/2009US7615553 E.g., N,N-dimethyl,((5-(hydroxyaminocarbonyl)pyrimidin-2-yl)(piperazin-1,4-ylene)sulfonamide; bioavailability; oral administration; metabolic stability; side effect reduction; psoriasis; anticarcinogenic -proliferative, -arthritic, -inflammatory agent; gene therapy; genetic transcription potentiation
11/10/2009US7615552 Fused heterocyclic compounds
11/10/2009US7615551 (8-{4-[3-(5 -Fluoro-1H-indol-3-yl)-propyl]-piperazin-1-yl}-2-methyl-4H-benzo[1,4]oxazin-3-one), for example; useful as modulator of one or more G-protein coupled receptors; for treating or lessening the severity of disorders selected from Parkinson's disease, psychoses depression, anxiety
11/10/2009US7615550 Such as 1-(4-{[1-(1-methylethyl)-4-piperidinyl]oxy}phenyl)-4-{[4-(methylsulfonyl)phenyl]carbonyl}piperazine; neurodegenerative disorders including Alzheimer's disease; allergic rhinitis
11/10/2009US7615549 Substituted pyrrolidinones, their manufacture and their use as medicaments
11/10/2009US7615548 Method to inhibit ischemia and reperfusion injury
11/10/2009US7615547 Granulates containing liposoluble substances and a process for the preparation thereof
11/10/2009US7615546 Topical delivery system for phytosterols
11/10/2009US7615545 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
11/10/2009US7615544 Method of improving cumulative embryo score and quantity of fertilized oocytes, increasing euploidy rate and of normalizing ovarian function using an androgen such as dehydroepiandrosterone
11/10/2009US7615543 Complexes with C-reactive protein (CRP) molecules; rheumatoid arthritis, juvenile chronic (rheumatoid) arthritis, ankylosing spondylitis, psoriatic arthritis, systemic vasculitis, polymyalgia rheumatica, Reiter's disease, Crohn's disease and familial Mediterranean fever
11/10/2009US7615542 Dioxolane thymine and combinations for use against 3TC/AZT resistant strains of HIV
11/10/2009US7615540 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening
11/10/2009US7615539 Nucleic acid-lipophilic conjugates
11/10/2009US7615536 Hyperlipidemia, arteriosclerosis and hypercholesterolemia treatment
11/10/2009US7615528 Methods for alleviating deleterious effects of 3-deoxyglucosone
11/10/2009US7615238 Plaster for the treatment of dysfunctions and disorders of nails, comprising sertaconazole
11/10/2009US7615230 Method for decreasing sebum production
11/10/2009US7615227 Using cytosine and guanine oligonucleotide as activators of neovascularization; for use in tissue repair and grafting
11/10/2009US7615210 Treatment of endometriosis
11/10/2009US7615207 Methods for treating irritable bowel syndrome
11/10/2009CA2590735C Process for the preparation of 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl) ethoxy}-5-tetrahydropyran-4-yloxyquinazoline, their intermediates and crystalline salts thereof
11/10/2009CA2551737C Helix 12 directed steroidal pharmaceutical products
11/10/2009CA2513064C Nanoparticulate topiramate formulations
11/10/2009CA2491632C Pyrimidinylaminobenzamide derivatives and their use as inhibitors of tyrosine kinases
11/10/2009CA2481482C Tropane derivatives as ccr5 modulators
11/10/2009CA2479476C Compositions and methods for the treatment of tumor
11/10/2009CA2476257C O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants
11/10/2009CA2459930C Method of treating middle ear infections
11/10/2009CA2457952C Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h) one derivatives for neurodegenerative disorders
11/10/2009CA2454500C Crystalline forms vi and vii of atorvastatin calcium
11/10/2009CA2444145C Preparation of formulations of angiotensin ii at1 receptors antagonists for the treatment of arterial hypertension, other cardiovascular illness and its complications
11/10/2009CA2425422C Stable desloratadine salts, process for their synthesis, and pharmaceutical compositions thereof
11/10/2009CA2421410C Iron compositions
11/10/2009CA2419887C Sulphur analogues of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op) for treating excess of glucocorticoids
11/10/2009CA2417401C Benzofuran derivatives and their use as antibacterial agents
11/10/2009CA2416785C Novel arylethene-sulfonamides
11/10/2009CA2411572C 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors
11/10/2009CA2410862C Factor viia inhibitory (thio)urea derivatives, their preparation and their use
11/10/2009CA2408292C Method for the preparation of citalopram
11/10/2009CA2401637C N-(heterocyclyl)benzene- or - pyridinesulphonamides as antithrombotic and anticoagulant agents
11/10/2009CA2397593C Pseudopolymorph of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8[4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one
11/10/2009CA2396351C New therapeutic combinations of (s)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro-7h-1,4-dioxino[2,3-e]indol-8-one and neuroleptics for the treatment or prevention of psychotic disorders
11/10/2009CA2382117C 4-substituted piperidine compound
11/10/2009CA2378792C Aminothiazole derivatives and their use as crf receptor ligands
11/10/2009CA2371213C Inhibitors of carboxypeptidase u
11/10/2009CA2368352C Method for treating neurodegeneration
11/10/2009CA2353460C Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds
11/10/2009CA2315262C Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
1 ... 2510 2511 2512 2513 2514 2515 2516 2517 2518 2519 2520 2521 2522 2523 2524 2525 2526 2527 2528 2529 2530 ... 7860